Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had revenue of $2.77B in the quarter ending September 30, 2024, with 11.61% growth. This brings the company's revenue in the last twelve months to $10.63B, up 10.06% year-over-year. In the year 2023, Vertex Pharmaceuticals had annual revenue of $9.87B with 10.51% growth.

• Revenue (ttm): $10.63B
• Revenue Growth: +10.06%
• P/S Ratio: 10.39
• Revenue / Employee: $1,967,741
• Employees: 5,400
• Market Cap: 110.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.87B	938.50M	10.51%
Dec 31, 2022	8.93B	1.36B	17.91%
Dec 31, 2021	7.57B	1.37B	22.06%
Dec 31, 2020	6.21B	2.04B	49.08%
Dec 31, 2019	4.16B	1.12B	36.59%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.